Meeting
2023 ASCO Gastrointestinal Cancers Symposium
A multicenter, case-control study of a novel multi-target fecal DNA test for colorectal cancer detection.
Authors
Jiaxi Peng
BGI Genomics, Shenzhen, China;
Jiaxi Peng , Meichen Yin , Ruijingfang Jiang , Zhilong Li , Duan Zhuo , Hongyue Qu , Mengxue Luo , Qian Liu , Weijia Jiang , Jianlong Sun , Jia Lin , Yuying Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Diagnostics
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 26)
DOI
10.1200/JCO.2023.41.4_suppl.26
Abstract #
26
Poster Bd #
B1
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Development and clinical validation of a blood test for early detection of colorectal adenomas and cancer.
First Author: Shai Friedland
Poster
2023 ASCO Annual Meeting
Neoplasia detection via colonoscopic surveillance among young patients with MSH6 and PMS2-associated Lynch syndrome.
First Author: Alicia Latham
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinical performance of a multimodal screening blood test for advanced adenomas and CRC in an average-risk cohort of 1,038 participants.
First Author: Shai Friedland
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Circulating nucleosomes for detection of colorectal cancer and high-risk advanced adenomas.
First Author: Li-Chun Chang